Insights

Biosimilar Growth Leverage Alvotech’s mission to broaden biosimilars accessibility to position partnerships with healthcare providers and payers showing demand for affordable biologics, presenting opportunities for joint marketing, supply chain optimization, and regulatory support services.

Scale & Sustainability Target biotechnology distributors and contract manufacturers aligned with sustainability goals, highlighting Alvotech’s focus on sustainable healthcare ecosystems to open channels for green manufacturing collaborations, packaging innovation, and lifecycle management services.

Digital Backbone Push for technology-enabled partnerships by offering integrations with Microsoft Azure, SharePoint and Teams to streamline collaboration, data sharing, and regulatory documentation for joint development programs and regional commercialization initiatives.

Financial Readiness With substantial funding and mid-to-large revenue scale, present opportunities for strategic investments, co-development deals, and licensing arrangements that align with investor expectations and accelerate regulatory approvals in key markets.

Market Momentum Capitalize on fluctuating short interest and market activity to engage with institutional investors, asset managers, and strategic acquirers by offering co-marketing, analytics partnerships, and revenue forecasts tied to biosimilar adoption trends.

Similar companies to Alvotech

Alvotech Tech Stack

Alvotech uses 8 technology products and services including Microsoft Power Apps, Veeam, Microsoft SharePoint, and more. Explore Alvotech's tech stack below.

Media & News

Alvotech's Email Address Formats

Alvotech uses at least 3 email formats:
Alvotech Email FormatsExamplePercentage
First.Last@alvotech.comJohn.Doe@alvotech.com
95%
FirstLa@alvotech.comJohnDo@alvotech.com
4%
FirstL@alvotech.comJohnD@alvotech.com
1%

Frequently Asked Questions

What is Alvotech's phone number?

Minus sign iconPlus sign icon
You can contact Alvotech's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Alvotech's stock symbol?

Minus sign iconPlus sign icon
Alvotech is a publicly traded company; the company's stock symbol is ALVOW.

What is Alvotech's official website and social media links?

Minus sign iconPlus sign icon
Alvotech's official website is alvotech.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Alvotech generate?

Minus sign iconPlus sign icon
As of October 2026, Alvotech's annual revenue is estimated to be $500M - $1B.

What is Alvotech's SIC code and NAICS code?

Minus sign iconPlus sign icon
Alvotech's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Alvotech have currently?

Minus sign iconPlus sign icon
As of October 2026, Alvotech has approximately 1.2K employees across 6 continents, including Europe, Asia and North America. Key team members include Cmo Qa Sr Lead: M. Á. D. D. F., Chief Financial Officer: L. J. and Chief Operating Officer: F. K. Explore Alvotech's employee directory with LeadIQ.

What industry does Alvotech belong to?

Minus sign iconPlus sign icon
Alvotech operates in the Biotechnology Research industry.

What technology does Alvotech use?

Minus sign iconPlus sign icon
Alvotech's tech stack includes Microsoft Power Apps, Veeam, Microsoft SharePoint, Microsoft Active Directory, Microsoft Azure, Microsoft Teams, Adobe Creative Suite and Piwik PRO Core.

What is Alvotech's email format?

Minus sign iconPlus sign icon
Alvotech's email format typically follows the pattern of First.Last@alvotech.com. Find more Alvotech email formats with LeadIQ.

How much funding has Alvotech raised to date?

Minus sign iconPlus sign icon
As of October 2026, Alvotech has raised $2B in funding. The last funding round occurred on Dec 31, 2025 for $78M.

When was Alvotech founded?

Minus sign iconPlus sign icon
Alvotech was founded in 2013.
Alvotech logo

Alvotech

Biotechnology ResearchReykjavík-1, Iceland1001-5000 Employees

Alvotech is a biotechnology research company based in Reykjavík, Iceland, operating from 15-19 Saemundargata, Reykjavík-1, 101. It focuses on biosimilars with a mission to improve patient lives and support the sustainability of the global healthcare ecosystem by broadening access to biosimilars. The company employs between 1,001 and 5,000 people. Its website is https://alvotech.com. Financial data indicate the business reports revenue in the hundreds of millions of dollars and has secured funding, though exact figures are not provided here.

Section iconCompany Overview

Phone number
SIC Code
8731 - Commercial Physical and Biological Research
Stock Symbol
ALVOW
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2013
Employees
1001-5000

Section iconFunding & Financials

  • $2B

    Alvotech has raised a total of $2B of funding over 12 rounds. Their latest funding round was raised on Dec 31, 2025 in the amount of $78M as a Post IPO Debt.

  • $500M - $1B

    Alvotech's revenue is estimated to be in the range of $500M - $1B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.